• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Neurosci Biobehav Rev . Neurotropism of SARS-CoV-2 and its neuropathological alterations: similarities with other coronaviruses

tetano

Editor, Senior Moderator
Neurosci Biobehav Rev


. 2020 Oct 19;119:184-193.
doi: 10.1016/j.neubiorev.2020.10.012. Online ahead of print.
Neurotropism of SARS-CoV-2 and its neuropathological alterations: similarities with other coronaviruses


Jingman Hu[SUP] 1 [/SUP], Jukka Jolkkonen[SUP] 2 [/SUP], Chuansheng Zhao[SUP] 3 [/SUP]



Affiliations

Abstract

A novel coronavirus (SARS-CoV-2) emerged from Wuhan, China, and spread quickly around the world. In addition to fever, cough and shortness of breath, it was confirmed that the patients also have manifestations towards the central nervous system (CNS), especially those critically ill ones. In this review, we will discuss how SARS-CoV-2 gain access to the CNS and the possible consequences. Both SARS-CoV-2 and SARS-CoV-1 in 2002 share the same receptor angiotensin-converting enzyme 2 (ACE2), which can be found in the brain and mediate the disease process. Both direct attack of SARS-CoV-2 and the abnormal immune response in the CNS would contribute to the disease. Also, there is a relationship between SARS-CoV-2 and the occurrence of acute cerebrovascular diseases.

Keywords: COVID-19; coronavirus; nervous system; neuropathological alterations.
 
Back
Top Bottom